Telesis Bio Buy Hold or Sell Recommendation

TBIODelisted Stock  USD 2.98  0.02  0.67%   
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Telesis Bio is 'Not Rated'. The recommendation algorithm takes into account all of Telesis Bio's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
In addition, we conduct extensive research on individual companies such as Telesis and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Telesis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Telesis Bio Buy or Sell Advice

The Telesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telesis Bio. Macroaxis does not own or have any residual interests in Telesis Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telesis Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Telesis BioBuy Telesis Bio
Not Rated
For the selected time horizon Telesis Bio has a Risk Adjusted Performance of 0.0593, Jensen Alpha of 1.47, Total Risk Alpha of (1.34), Sortino Ratio of 0.0883 and Treynor Ratio of (0.85)
We provide advice to complement the current expert consensus on Telesis Bio. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Telesis Bio is not overpriced, please validate all Telesis Bio fundamentals, including its price to sales, book value per share, working capital, as well as the relationship between the cash and equivalents and number of employees . Please also confirm Telesis Bio number of shares shorted to double-check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Telesis Bio Trading Alerts and Improvement Suggestions

Telesis Bio is not yet fully synchronised with the market data
Telesis Bio is way too risky over 90 days horizon
Telesis Bio appears to be risky and price may revert if volatility continues
Telesis Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 27.51 M. Net Loss for the year was (47.72 M) with profit before overhead, payroll, taxes, and interest of 15.6 M.
Telesis Bio currently holds about 654.75 M in cash with (34.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 38.0% of the company outstanding shares are owned by corporate insiders

Telesis Bio Returns Distribution Density

The distribution of Telesis Bio's historical returns is an attempt to chart the uncertainty of Telesis Bio's future price movements. The chart of the probability distribution of Telesis Bio daily returns describes the distribution of returns around its average expected value. We use Telesis Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telesis Bio returns is essential to provide solid investment advice for Telesis Bio.
Mean Return
1.33
Value At Risk
-19.05
Potential Upside
18.58
Standard Deviation
20.41
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telesis Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Nachtsheim Jami K of 70129 shares of Telesis Bio at 1.54 subject to Rule 16b-3 [view details]

Telesis Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Telesis Bio Buy or Sell Advice

When is the right time to buy or sell Telesis Bio? Buying financial instruments such as Telesis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Telesis Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Buywrite ETFs Thematic Idea Now

Buywrite ETFs
Buywrite ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Buywrite ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Buywrite ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity